Toxicity Evaluation of Methoxy Poly(ethylene Oxide)--poly(ε-caprolactone) Polymeric Micelles Following Multiple Oral and Intraperitoneal Administration to Rats

Overview

Journal Saudi Pharm J

Specialty Pharmacy

Date 2017 Sep 28

PMID 28951683

Citations 5

Authors

Ziyad Binkhathlan

Wajhul Qamar

Raisuddin Ali

Hala Kfoury

Mohammed Alghonaim

Affiliations

Soon will be listed here.

Abstract

Methoxy poly(ethylene oxide)--poly(ɛ-caprolactone) (PEO--PCL) copolymers are amphiphilic and biodegradable copolymers designed to deliver a variety of drugs and diagnostic agents. The aim of this study was to synthesize PEO--PCL block copolymers and assess the toxic effects of drug-free PEO--PCL micelles after multiple-dose administrations via oral or intraperitoneal (ip) administration in rats. Assembly of block copolymers was achieved by co-solvent evaporation method. To investigate the toxicity profile of PEO--PCL micelles, sixty animals were divided into two major groups: The first group received PEO--PCL micelles (100 mg/kg) by oral gavage daily for seven days, while the other group received the same dose of micelles by ip injections daily for seven days. Twenty-four hours following the last dose, half of the animals from each group were sacrificed and blood and organs (lung, liver, kidneys, heart and spleen) were collected. Remaining animals were observed for further 14 days and was sacrificed at the end of the third week, and blood and organs were collected. None of the polymeric micelles administered caused any significant effects on relative organ weight, animal body weight, leucocytes count, % lymphocytes, liver and kidney toxicity markers and organs histology. Although the dose of copolymers used in this study is much higher than those used for drug delivery, it did not cause any significant toxic effects in rats. Histological examination of all the organs confirmed the nontoxic nature of the micelles.

Citing Articles

Hyperelastic, shape-memorable, and ultra-cell-adhesive degradable polycaprolactone-polyurethane copolymer for tissue regeneration.

Hong S, Yoon J, Cha J, Ahn J, Mandakhbayar N, Park J Bioeng Transl Med. 2022; 7(3):e10332.

PMID: 36176615 PMC: 9472029. DOI: 10.1002/btm2.10332.

A Multifunctional Polymeric Micelle for Targeted Delivery of Paclitaxel by the Inhibition of the P-Glycoprotein Transporters.

Razzaq S, Rauf A, Raza A, Akhtar S, Tabish T, Sandhu M Nanomaterials (Basel). 2021; 11(11).

PMID: 34835622 PMC: 8618187. DOI: 10.3390/nano11112858.

Polymeric micelles for the ocular delivery of triamcinolone acetonide: preparation and evaluation in a rabbit ocular inflammatory model.

Safwat M, Mansour H, Hussein A, Abdelwahab S, Soliman G Drug Deliv. 2020; 27(1):1115-1124.

PMID: 32720545 PMC: 7470058. DOI: 10.1080/10717544.2020.1797241.

Intra-articular drug delivery systems for joint diseases.

Rai M, Pham C Curr Opin Pharmacol. 2018; 40:67-73.

PMID: 29625332 PMC: 6015522. DOI: 10.1016/j.coph.2018.03.013.

Renewable poly(δ-decalactone) based block copolymer micelles as drug delivery vehicle: and evaluation.

Bansal K, Gupta J, Rosling A, Rosenholm J Saudi Pharm J. 2018; 26(3):358-368.

PMID: 29556127 PMC: 5856948. DOI: 10.1016/j.jsps.2018.01.006.

References

Koudelka S, Knotigova P, Masek J, Prochazka L, Lukac R, Miller A . Liposomal delivery systems for anti-cancer analogues of vitamin E. J Control Release. 2015; 207:59-69. DOI: 10.1016/j.jconrel.2015.04.003. View

Montazeri Aliabadi H, Mahmud A, Sharifabadi A, Lavasanifar A . Micelles of methoxy poly(ethylene oxide)-b-poly(epsilon-caprolactone) as vehicles for the solubilization and controlled delivery of cyclosporine A. J Control Release. 2005; 104(2):301-11. DOI: 10.1016/j.jconrel.2005.02.015. View

Haley B, Frenkel E . Nanoparticles for drug delivery in cancer treatment. Urol Oncol. 2008; 26(1):57-64. DOI: 10.1016/j.urolonc.2007.03.015. View

Montazeri Aliabadi H, Lavasanifar A . Polymeric micelles for drug delivery. Expert Opin Drug Deliv. 2005; 3(1):139-62. DOI: 10.1517/17425247.3.1.139. View

Diehl K, Hull R, Morton D, Pfister R, Rabemampianina Y, Smith D . A good practice guide to the administration of substances and removal of blood, including routes and volumes. J Appl Toxicol. 2001; 21(1):15-23. DOI: 10.1002/jat.727. View

Weissig V, Guzman-Villanueva D . Nanopharmaceuticals (part 2): products in the pipeline. Int J Nanomedicine. 2015; 10:1245-57. PMC: 4334342. DOI: 10.2147/IJN.S65526. View

Mahmud A, Xiong X, Montazeri Aliabadi H, Lavasanifar A . Polymeric micelles for drug targeting. J Drug Target. 2007; 15(9):553-84. DOI: 10.1080/10611860701538586. View

Montazeri Aliabadi H, Brocks D, Mahdipoor P, Lavasanifar A . A novel use of an in vitro method to predict the in vivo stability of block copolymer based nano-containers. J Control Release. 2007; 122(1):63-70. DOI: 10.1016/j.jconrel.2007.06.008. View

Li Y, Dong H, Li Y, Shi D . Graphene-based nanovehicles for photodynamic medical therapy. Int J Nanomedicine. 2015; 10:2451-9. PMC: 4383220. DOI: 10.2147/IJN.S68600. View

10.

Jette K, Law D, Schmitt E, Kwon G . Preparation and drug loading of poly(ethylene glycol)-block-poly(epsilon-caprolactone) micelles through the evaporation of a cosolvent azeotrope. Pharm Res. 2004; 21(7):1184-91. DOI: 10.1023/b:pham.0000033005.25698.9c. View

11.

Xiong M, Yanez J, Remsberg C, Ohgami Y, Kwon G, Davies N . Formulation of a geldanamycin prodrug in mPEG-b-PCL micelles greatly enhances tolerability and pharmacokinetics in rats. J Control Release. 2008; 129(1):33-40. PMC: 2492396. DOI: 10.1016/j.jconrel.2008.03.015. View

12.

Wei X, Gong C, Gou M, Fu S, Guo Q, Shi S . Biodegradable poly(epsilon-caprolactone)-poly(ethylene glycol) copolymers as drug delivery system. Int J Pharm. 2009; 381(1):1-18. DOI: 10.1016/j.ijpharm.2009.07.033. View

13.

Farokhzad O, Langer R . Impact of nanotechnology on drug delivery. ACS Nano. 2009; 3(1):16-20. DOI: 10.1021/nn900002m. View

14.

Bozzuto G, Molinari A . Liposomes as nanomedical devices. Int J Nanomedicine. 2015; 10:975-99. PMC: 4324542. DOI: 10.2147/IJN.S68861. View

15.

Binkhathlan Z, Hamdy D, Brocks D, Lavasanifar A . Development of a polymeric micellar formulation for valspodar and assessment of its pharmacokinetics in rat. Eur J Pharm Biopharm. 2010; 75(2):90-5. DOI: 10.1016/j.ejpb.2010.03.010. View

16.

Shin I, Kim S, Lee Y, Cho C, Sung Y . Methoxy poly(ethylene glycol)/epsilon-caprolactone amphiphilic block copolymeric micelle containing indomethacin. I. Preparation and characterization. J Control Release. 1998; 51(1):1-11. DOI: 10.1016/s0168-3659(97)00164-8. View

17.

Montazeri Aliabadi H, Elhasi S, Mahmud A, Gulamhusein R, Mahdipoor P, Lavasanifar A . Encapsulation of hydrophobic drugs in polymeric micelles through co-solvent evaporation: the effect of solvent composition on micellar properties and drug loading. Int J Pharm. 2006; 329(1-2):158-65. DOI: 10.1016/j.ijpharm.2006.08.018. View

18.

Lukowiak M, Thota B, Haag R . Dendritic core-shell systems as soft drug delivery nanocarriers. Biotechnol Adv. 2015; 33(6 Pt 3):1327-41. DOI: 10.1016/j.biotechadv.2015.03.014. View

19.

Turner P, Brabb T, Pekow C, Vasbinder M . Administration of substances to laboratory animals: routes of administration and factors to consider. J Am Assoc Lab Anim Sci. 2012; 50(5):600-13. PMC: 3189662. View

20.

Forrest M, Won C, Malick A, Kwon G . In vitro release of the mTOR inhibitor rapamycin from poly(ethylene glycol)-b-poly(epsilon-caprolactone) micelles. J Control Release. 2005; 110(2):370-377. DOI: 10.1016/j.jconrel.2005.10.008. View